Electronic Prescribing and Electronic Transmission of Discharge Medication Lists

This study is currently recruiting participants.

Verified by Weill Medical College of Cornell University, November 2008

Sponsors and Collaborators:	Weill Medical College of Cornell University Agency for Healthcare Research and Quality (AHRQ) New York Presbyterian Hospital Columbia University Oregon Health and Science University
Information provided by:	Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:	NCT00603070

Purpose

The purpose of this study is twofold:

to measure the effects of transitioning from one electronic prescribing system to another in the ambulatory setting on medication errors and human-computer interactions
to evaluate the impact of electronic transmission of discharge medication lists to the ambulatory setting on medication discrepancies and adverse drug events

Condition	Intervention
Medication Errors	Other: E-prescribing system Other: Electronic transmission of medication discharge lists

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Prospective
Official Title:	Electronic Prescribing and Electronic Transmission of Discharge Medication Lists to Improve Ambulatory Medication Safety

Further study details as provided by Weill Medical College of Cornell University:

Primary Outcome Measures:

Prescription medication errors [ Time Frame: 2 weeks prior, 3 months and 1 year after intervention ] [ Designated as safety issue: Yes ]
Medication discrepancies (as detected on a comparison between inpatient and outpatient medical records) [ Time Frame: 30 days after patient is discharged from hospital ] [ Designated as safety issue: Yes ]
Patient adverse drug events (as determined by patient telephone interview and medical record review) [ Time Frame: 30 days after patient hospital discharge ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:

Human-Computer interactions as measured by physician interview and direct observation of physician work [ Time Frame: 3 months after intervention ] [ Designated as safety issue: No ]

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	130
Study Start Date:	March 2008
Estimated Study Completion Date:	September 2010
Estimated Primary Completion Date:	June 2010 (Final data collection date for primary outcome measure)

Groups/Cohorts	Assigned Interventions
1 All physicians and nurse practitioners at 2 ambulatory care clinics	Other: E-prescribing system Transition from home-grown to vendor-based ambulatory e-prescribing systems
2 Half of all physicians and nurse practitioners at 2 ambulatory care clinics	Other: Electronic transmission of medication discharge lists Patient discharge medication lists will be transmitted upon discharge from their inpatient medical record to their outpatient medical record and their outpatient provider will be notified of this transmission.
3 Half of all physicians and nurse practitioners at 2 ambulatory care clinics

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Probability Sample

Study Population

Physicians and Nurse Practitioners from 2 office practices in the Ambulatory Care Network at NYPH, Associates in Internal Medicine (AIM) on the Columbia campus and Cornell Internal Medicine Associates (CIMA) on the Cornell campus.

Criteria

Inclusion Criteria:

Physicians or nurse practitioners with at least 4 clinic sessions per week

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00603070

Contacts

Contact: Heather C O'Donnell, MD

(212)746-1261

heo9006@med.cornell.edu

Locations

United States, New York
Weill Cornell Internal Medicine Associates	Not yet recruiting
New York, New York, United States, 10021
Associates in Internal Medicine (AIM)	Recruiting
New York, New York, United States, 10032

Sponsors and Collaborators

Weill Medical College of Cornell University

Agency for Healthcare Research and Quality (AHRQ)

New York Presbyterian Hospital

Columbia University

Oregon Health and Science University

Investigators

Principal Investigator:

Rainu Kaushal, MD, MPH

Weill Cornell Medical College

More Information

Responsible Party:	Weill Cornell Medical College ( Rainu Kaushal, MD, MPH )
Study ID Numbers:	R18-HS017029-01
Study First Received:	January 15, 2008
Last Updated:	November 14, 2008
ClinicalTrials.gov Identifier:	NCT00603070
Health Authority:	United States: Institutional Review Board

Keywords provided by Weill Medical College of Cornell University:

Medication Errors
Adverse Drug Events
Patient Safety
Electronic Prescribing Systems
Medication Reconciliation

ClinicalTrials.gov processed this record on January 14, 2009